Comparing blood glucose measurement methods for diabetes patients
Istanbul University Cerrahpaşa-IUC
NA · Istanbul University - Cerrahpasa · NCT05976191
This study tests whether people with Type 2 diabetes prefer blood sugar tests done with fingertip pricks or through an IV while they are in the hospital.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 110 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | Istanbul University - Cerrahpasa (other) |
| Locations | 2 sites (Istanbul, Şişli and 1 other locations) |
| Trial ID | NCT05976191 on ClinicalTrials.gov |
What this trial studies
This study compares the fasting blood glucose levels measured from fingertip pricks versus intravenous methods in patients with diabetes mellitus. It aims to evaluate patient satisfaction with each method, hypothesizing that intravenous measurement may enhance comfort and satisfaction. The study is designed as a randomized controlled trial, focusing on hospitalized patients who have been diagnosed with Type 2 Diabetes Mellitus for at least one year. Participants will be monitored for their responses to both measurement techniques.
Who should consider this trial
Good fit: Ideal candidates are hospitalized adults aged 18 and older with Type 2 Diabetes Mellitus who can communicate effectively and consent to participate.
Not a fit: Patients with advanced cognitive impairments, those on sedative or antipsychotic medications, or those requiring continuous drug infusion may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved patient satisfaction and comfort in blood glucose monitoring for diabetes patients.
How similar studies have performed: While similar studies have explored patient comfort in blood glucose monitoring, this specific comparison of intravenous versus fingertip methods is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years and older * No advanced hearing and vision problems * Able to speak and understand Turkish * Easy to communicate * literate * Agreeing to participate in the research voluntarily * Patients who are hospitalized * Regular finger blood sugar monitoring, * Patients with an intravenous vascular access date within the first 24 hours * Patients who had been diagnosed with Type 2 Diabetes Mellitus for at least one year were. Exclusion Criteria: * Those who are treated with sedative drugs * Patients using antipsychotic medication * Patients with continuous drug infusion through the intravenous line * Patients whose intravenous vascular access date has passed 24 hours * Patients in unconscious, confused, apathetic state
Where this trial is running
Istanbul, Şişli and 1 other locations
- Istanbul University-Cerrahpaşa (IUC) — Istanbul, Şişli, Turkey (RECRUITING)
- Istanbul University-Cerrahpaşa (IUC) — Istanbul, Şişli, Turkey (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Diabetes Mellitus, Diabetes mellitus, Fear of finger piercing, patient satisfaction, blood glucose measurement